29.21MMarket Cap-0.44P/E (TTM)
0.506High0.465Low74.50KVolume0.480Open0.470Pre Close35.74KTurnover0.15%Turnover RatioLossP/E (Static)62.15MShares1.69052wk High0.48P/B22.86MFloat Cap0.38052wk Low--Dividend TTM48.63MShs Float38.230Historical High--Div YieldTTM8.76%Amplitude0.380Historical Low0.479Avg Price1Lot Size
Passage Bio Stock Forum
$15M dilution
Passage Bio Announces Interim Data from upliFT-D Study in FTD-GRN and Provides Business Updates
Friday, 10th January at 7:00 am
PBFT02 demonstrated durable, elevated CSF PGRN levels and early evidence of reduction in plasma NfL levels, a disease progression biomarker, compared to published natural history data
Evaluating Dose 2, 50% lower than Dose 1, in subsequent FTD-GRN and FTD-C9orf72 patients to allow for dose exploration and support regulatory strategy
Expect to ...
NOTE!
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 CH (cash on hand); AH (after hours): RTH (regular trading hours)
7. Remember, some stocks may get pumped WITHOUT any catalyst
8. It’s 2025, those newbies need to read and educate themselves on stocks. ...
No comment yet